Presentation-SBP GROUP | Sino Biopharmaceutical Limited

Stock Symbol 01177

About Us
R&D
Products
News
Sustainability
Investors
Careers

CN EN

Investors

Investors

Home> Investors> Presentation

Information Disclosure
Corporate Governance
Presentation
Investor FAQs
Notices

Presentation

SBP Group 2025 Annual Results Announcement

2026.03.26
SBP Group 2025 Interim Results Announcement

2025.08.18
SBP Group 2024 Annual Results Announcement

2025.03.20
SBP Group 2024 Interim Results Announcement

2024.09.19
SBP Group 2024 JPM Annual Healthcare Conference

2024.01.11
SBP Group 2022 Annual Results Announcement

2023.06.01
SBP Group 2023 JPM Annual Healthcare Conference

2023.01.16

About Us: About SBP GROUP Management Team Major Events

R&D

Products: Innovative Products Oncology Hepatology/Cardiometabolism Respiratory/Autoimmunity Surgery/Analgesia Others

News

Sustainability: ESG Strategy and Governance ESG Policies and Commitments ESG Dynamics ESG Reports

Investors: Information Disclosure Corporate Governance Presentation Investor FAQs Notices

Careers

Contact Us: Beijing Headquarters: 45 Floor, CP Center North Tower, 10 Guanghua Road, Chaoyang District, Beijing, China Tel：(+86)10 59257399 E-mail：info@cppharm.com PR：pr@sbpgroup.com; Hong Kong Headquarters: Unit 09, 41/F, Office Tower, Convention Plaza, 1 Harbour Road, Wan Chai, Hong Kong Tel：(+852) 2802 9886 E-mail: info@sbpgroup.com

Complaint and Report: Complaint and Report E-mail：sjjcb@cttq.com

Legal Terms|Contact Us|Privacy Policy

© 2023 Sino Biopharmaceutical Limited. All rights reserved.

Links: CP Group invoX Pharma Limited CTTQ Pharmaceutical Beijing Tide Pharmaceutical Nanjing Chiatai Tianqing Pharmaceutical HYGIEIA Pharmaceuticals LaNova Medicines Limited Jiangsu Chiatai Qingjiang Pharmaceutical Jiangsu Chiatai FenghaiPharmaceutical